Position in NVS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$40,423,607
+$5,766,536 QoQ
Shares Held
264,639
+5.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$20,194
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $4,563,556,722 across 16 Drug Manufacturers - General names. NVS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,484,201 | $2,562,758,092 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,635,404 | $437,302,747 | |
| 3 | LLY |
ELI LILLY & Co
|
440,797 | $405,431,856 | |
| 4 | ABBV |
AbbVie Inc.
|
1,658,024 | $360,603,639 | |
| 5 | AMGN |
Amgen Inc
|
820,320 | $288,629,592 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,450,177 | $202,111,168 | |
| 7 | AZN |
Astrazeneca PLC
|
475,948 | $93,866,464 | |
| 8 | PFE |
Pfizer Inc
|
2,648,143 | $74,359,855 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,423,607 | 264,639 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $34,657,071 | 251,375 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $32,470,752 | 253,203 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $29,364,286 | 242,660 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $26,514,514 | 237,841 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,902,200 | 235,353 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $33,454,717 | 290,860 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,495,978 | 295,848 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,656,552 | 296,253 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $29,177,199 | 288,969 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $20,194 | 200 | Put | Sole | 2024-02-12 | |
| 2023-09-30 | $28,785,636 | 282,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $26,555,980 | 263,165 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,188,508 | 252,049 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,356,946 | 246,439 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,564,606 | 244,239 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $20,593,621 | 243,625 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $26,337,460 | 300,142 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $26,782,701 | 306,193 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $25,231,174 | 308,525 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $28,454,562 | 311,865 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $25,569,717 | 299,131 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $26,741,537 | 283,189 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $21,153,454 | 243,255 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $19,049,028 | 218,102 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $18,090,601 | 219,413 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||